Literature DB >> 7647781

Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2.

H A Phillips, I E Scheffer, S F Berkovic, G E Hollway, G R Sutherland, J C Mulley.   

Abstract

The epilepsies comprise a group of syndromes that are divided into generalized and partial (focal) types. Familial occurrence has long been recognized but progress in mapping epilepsy genes has been slow except for rare cases where the inheritance is easily determined from classical genetic studies. Linkage is established for three generalized syndromes: the EBN1 and EBN2 genes for benign familial neonatal convulsions (BFNC) map to chromosomes 20q and 8q (refs 2-5), the EPM1 gene for Unverricht-Lundborg disease maps to 21q (ref. 6) and the gene for the northern epilepsy syndrome maps to 8p (ref. 7). A claim for linkage of the EJM1 gene for the common generalized syndrome of juvenile myoclonic epilepsy to 6p is currently in dispute. Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) was recently described in five families. We now report the chromosomal assignment, to 20q13.2, for the gene for ADNFLE in one large Australian kindred with 27 affected individuals spanning six generations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647781     DOI: 10.1038/ng0595-117

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  37 in total

Review 1.  Genetics of childhood epilepsy.

Authors:  R Robinson; M Gardiner
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

2.  Search for alpha4 and alpha7 nicotinic acetylcholine receptor markers in a pedigree of benign familial infantile convulsions (BFIC).

Authors:  M B Rauschemberger; C Vecchi; F J Barrantes
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

3.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 4.  Nocturnal frontal lobe epilepsy.

Authors:  Lino Nobili; Paola Proserpio; Romina Combi; Federica Provini; Giuseppe Plazzi; Francesca Bisulli; Laura Tassi; Paolo Tinuper
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

5.  Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24.

Authors:  H A Phillips; I E Scheffer; K M Crossland; K P Bhatia; D R Fish; C D Marsden; S J Howell; J B Stephenson; J Tolmie; G Plazzi; O Eeg-Olofsson; R Singh; I Lopes-Cendes; E Andermann; F Andermann; S F Berkovic; J C Mulley
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

6.  Segregation analysis of cryptogenic epilepsy and an empirical test of the validity of the results.

Authors:  R Ottman; W A Hauser; C Barker-Cummings; J H Lee; N Risch
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

7.  Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy.

Authors:  David N Bowser; David A Wagner; Cynthia Czajkowski; Brett A Cromer; Michael W Parker; Robyn H Wallace; Louise A Harkin; John C Mulley; Carla Marini; Samuel F Berkovic; David A Williams; Mathew V Jones; Steven Petrou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

8.  Familial aggregation of focal seizure semiology in the Epilepsy Phenome/Genome Project.

Authors:  Steven Tobochnik; Robyn Fahlstrom; Catherine Shain; Melodie R Winawer
Journal:  Neurology       Date:  2017-05-31       Impact factor: 9.910

Review 9.  Neurodevelopmental liabilities in epilepsy.

Authors:  Antonio Gil-Nagel
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Demonstration of functional alpha4-containing nicotinic receptors in the medial habenula.

Authors:  Carlos Fonck; Raad Nashmi; Ramiro Salas; Chunyi Zhou; Qi Huang; Mariella De Biasi; Robin A J Lester; Henry A Lester
Journal:  Neuropharmacology       Date:  2008-08-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.